Pelthos Therapeutics (NYSEAM:PTHS) FY Conference Transcript
2026-03-23 23:02
Pelthos Therapeutics (NYSEAM:PTHS) FY Conference March 23, 2026 06:00 PM ET Company ParticipantsFrank Knuettel II - CFOScott Plesha - CEOConference Call ParticipantsJonathan Aschoff - Senior Biotechnology AnalystJonathan AschoffWelcome back. This is Jonathan Aschoff, Senior Biotechnology Analyst at Roth Capital Partners. With me now from Pelthos Therapeutics is CEO Scott Plesha and CFO Frank Knuettel II. Welcome, guys.Scott PleshaThanks, Jonathan.Jonathan AschoffWe'll start this off. Give us some background ...